INTRODUCTION
STUDY GOAL AND OBJECTIVES
BCC's goal in conducting this study was to provide a comprehensive overview
of the imaging reagent market and its future direction, with emphasis on the use
of reagents used in imaging technology. The study was also conducted to describe
the types, market size and market leaders of imaging reagents. The report deals
with the questions like: What is imaging? What are the current and potential
applications of imaging reagents? What is the U.S./worldwide market value of
imaging reagents? And finally, What is the market value of emerging imaging
reagents? The basic principles behind all types of imaging-x-rays, ultrasound,
magnetic resonance, radiopharmaceuticals, and ionic and non-ionic-are also
discussed with their usage over a five-year period from 2003 to 2008. The
companies selling these products were brought to the forefront and also the
factors affecting markets for these products, and how those markets are likely
to change.
REASONS FOR DOING THE STUDY
The imaging market is changing due to the demand for safe and less costly
reagents. The key, current objective focuses on the use of non-ionic reagents.
The available alternatives and preferences in using various reagents for imaging
have made the industry acutely aware of the issues covered in the report and the
economic characteristics. This study looks at almost all the types of imaging
markets affected by these factors. The rapid development of the technologies,
major changes in market behavior, and the high impact that imaging technology
has upon healthcare expenses all justify focusing on this segment. Cardiovascular
reagents have a large share of the imaging reagent market. More reagents are
being discovered for the use in imaging technology with an emphasis on
enhancers, which give more precise images. A bright future is foreseen for
central nervous system and gastrointestinal imaging reagents over next few
years. The growth of acquisition strategies and collaborations by companies to
gain better market share is also covered in this report. This study discusses
the strengths and weaknesses of reagents in the market in light of new
technologies, growing competition, and changing customer needs.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study contributes by bringing together in one place much of the
information on new products and new technologies in imaging reagents as well as
estimates of how the market will perform over the next five years. Various
types of imaging techniques including x-rays, ultrasound, magnetic resonance,
and radiopharmaceuticals are presented. The regulations governing their use,
technological descriptions and issues, applications, market factors and
potential, and the projected market for 2003 and 2008 are also discussed. This
study will be of interest to the pharmaceutical industry, biochemical companies,
physicians, and the research companies developing new imaging reagents.
SCOPE AND FORMAT
The scope of this study encompasses the different types of imaging
technologies and the types of reagents used in those particular technologies.
BCC analyzes each technique and concentrates on the manufacturers, new products,
sales estimates, and market projections and market share information.
Technological issues including the latest trends and developments are also
discussed. Government regulations are examined, including those of the FDA,
which approves the use of these reagents . Significant imaging reagent related
patents are also listed.
METHODOLOGY
A comprehensive literature and patent search was conducted. The literature
included technical newsletters and journals, as well as many other sources. The
data was collected through interviews/mails of various analytical/chemical and
pharmaceutical companies. This data was complied and the projections were based
on such estimates such as the current number of end users, potential end users,
likely unit prices, rates of consumption and the market trends.
INFORMATION SOURCES
BCC surveyed many companies to obtain data for this study. Included were
manufacturers and the end users of the imaging reagents. We gathered the data
from these industries, also spoke with officials of these industries, consulted
newsletters, company literature, product literature, a host of technical
articles, journals, indexes, and abstracts. Exhaustive investigations of
databases by key terminology were performed. In addition, data was compiled from
current financial and trade information and government sources. | 
View Cart
